IBM Retirement Fund lessened its position in Morgan Stanley (NYSE:MS) by 3.8% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 31,709 shares of the financial services provider’s stock after selling 1,236 shares during the period. IBM Retirement Fund’s holdings in Morgan Stanley were worth $1,825,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently made changes to their positions in the business. Exane Derivatives lifted its holdings in shares of Morgan Stanley by 303.9% in the fourth quarter. Exane Derivatives now owns 1,979 shares of the financial services provider’s stock valued at $104,000 after purchasing an additional 1,489 shares in the last quarter. First Dallas Securities Inc. bought a new position in shares of Morgan Stanley in the fourth quarter valued at approximately $121,000. Invictus RG lifted its holdings in shares of Morgan Stanley by 307.5% in the third quarter. Invictus RG now owns 2,335 shares of the financial services provider’s stock valued at $112,000 after purchasing an additional 1,762 shares in the last quarter. Rational Advisors LLC bought a new position in shares of Morgan Stanley in the third quarter valued at approximately $116,000. Finally, Zions Bancorporation lifted its holdings in shares of Morgan Stanley by 176.1% in the third quarter. Zions Bancorporation now owns 2,463 shares of the financial services provider’s stock valued at $119,000 after purchasing an additional 1,571 shares in the last quarter. 86.55% of the stock is owned by hedge funds and other institutional investors.
A number of research analysts have recently weighed in on MS shares. Keefe, Bruyette & Woods restated a “buy” rating and issued a $63.00 target price on shares of Morgan Stanley in a report on Friday, December 22nd. Zacks Investment Research upgraded Morgan Stanley from a “hold” rating to a “buy” rating and set a $59.00 target price on the stock in a report on Monday, December 11th. JPMorgan Chase & Co. restated a “buy” rating on shares of Morgan Stanley in a report on Monday, November 20th. Buckingham Research raised their target price on Morgan Stanley from $54.00 to $57.00 and gave the company a “buy” rating in a report on Wednesday, October 18th. Finally, Credit Suisse Group upgraded Morgan Stanley to a “buy” rating and set a $58.00 target price on the stock in a report on Thursday, January 4th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $54.07.
Morgan Stanley (NYSE:MS) last issued its quarterly earnings results on Thursday, January 18th. The financial services provider reported $0.84 EPS for the quarter, topping the Zacks’ consensus estimate of $0.77 by $0.07. The business had revenue of $9.50 billion for the quarter, compared to analyst estimates of $9.25 billion. Morgan Stanley had a return on equity of 10.03% and a net margin of 14.10%. Morgan Stanley’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same period last year, the company posted $0.81 earnings per share. analysts anticipate that Morgan Stanley will post 4.51 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Wednesday, January 31st will be paid a $0.25 dividend. The ex-dividend date is Tuesday, January 30th. This represents a $1.00 annualized dividend and a dividend yield of 1.92%. Morgan Stanley’s payout ratio is presently 32.36%.
In other Morgan Stanley news, Director Alistair Darling sold 3,850 shares of the business’s stock in a transaction on Friday, November 24th. The stock was sold at an average price of $49.29, for a total value of $189,766.50. Following the sale, the director now directly owns 14,218 shares in the company, valued at $700,805.22. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Keishi Hotsuki sold 25,000 shares of the business’s stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $50.00, for a total value of $1,250,000.00. The disclosure for this sale can be found here. Insiders own 0.24% of the company’s stock.
TRADEMARK VIOLATION WARNING: “IBM Retirement Fund Trims Holdings in Morgan Stanley (MS)” was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://sportsperspectives.com/2018/02/12/ibm-retirement-fund-trims-holdings-in-morgan-stanley-ms.html.
Morgan Stanley Company Profile
Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.